Counterpoint Mutual Funds LLC acquired a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 28,717 shares of the company’s stock, valued at approximately $377,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Quest Partners LLC grew its position in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares in the last quarter. Parkside Financial Bank & Trust grew its position in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after acquiring an additional 1,040 shares in the last quarter. Quarry LP grew its position in Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. AlphaQuest LLC grew its position in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after acquiring an additional 2,012 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its position in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after acquiring an additional 6,090 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.
Pediatrix Medical Group Price Performance
MD stock opened at $14.26 on Tuesday. The business has a 50 day moving average price of $14.19 and a 200 day moving average price of $13.45. The stock has a market cap of $1.22 billion, a price-to-earnings ratio of -11.89, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.
Analyst Ratings Changes
MD has been the subject of a number of analyst reports. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Macquarie initiated coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Truist Financial boosted their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday, February 21st. UBS Group boosted their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. Finally, Mizuho boosted their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.08.
View Our Latest Stock Report on Pediatrix Medical Group
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Five stocks we like better than Pediatrix Medical Group
- What is Short Interest? How to Use It
- Can TikTok Stock Picks Really Make You Rich?
- What is a SEC Filing?
- The “Quality” Rotation: Back to Basics Investing
- High Flyers: 3 Natural Gas Stocks for March 2022
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.